pf

Givaudan Holds 2018 Annual Meeting

Contact Author
Close
Fill out my online form.

On March 22, 2018, Givaudan held its 2018 annual meeting, where they discussed 2017 financials and approved dividends.

The meeting was attended by 371 shareholders or proxies, representing 41.7% of total shares. All proposals by the board of directors were approved.

With 98.62% of votes the 2017 annual report, annual financial statements and the consolidated financial statement were approved. The company’s consultative basis compensation report was approved with 90.03% of votes.

A distribution of CHF 58.00 per share to holders was also approved; this is the seventeenth consecutive dividend increase following Givaudan’s listing at the Swiss stock exchange in 2000.

Related: Givaudan Group Announces 2017 Financials

Members of the board were discharged with 97.05% of votes. All current members were re-elected, each for a term of one year until the 2019 annual meeting, in accordance with the legal requirements and Givaudan’s Articles of Incorporation.

The board of directors includes:

  • Victor Balli
  • Ing Werner Bauer
  • Lilian Biner
  • Michael Carlos
  • Ingrid Deltenre
  • Calvin Grieder
  • Thomas Rufer

Balli and Deltenre were re-elected to the compensation committee for a term of one year. Additionally, Manuel Isler was re-elected as independent shareholder representative until 2019, and Deloitte SA was re-elected as auditors for the financial year of 2018, with Karine Szegedi Pingoud serving as lead auditor, partner.

Other approved items include:

  • Maximum aggregate amount of compensation of the Board of Directors of CHF 2,950,000 for the term until the 2019 annual general meeting (97.04% of the votes).
  • Aggregate amount of short-term variable compensation of the executive committee for the fiscal year 2017 of CHF 3,490,698 by 97.07% of the votes.
  • Maximum aggregate amount of fixed and long-term variable compensation of the executive committee for the fiscal year 2018 of CHF 17,000,000, by 91.77% of the votes.